Seroquel XR gets approved in the USA
The US Food and Drug Administration has given the green light to AstraZeneca’s bipolar extended release treatment Seroquel XR (quetiapine fumarate).
Read MoreAuthor: Katrina Megget
Vernalis and Servier reach milestone
France’s largest privately-owned pharmaceutical company, Servier, and UK partner Vernalis have announced the achievement of the first milestone in their oncology drug discovery collaboration.
Read MoreRoche hits another brick wall in Mircera saga
Roche’s anaemia drug Mircera has been barred from the USA after a US appeals court upheld a previous ruling alleging the Swiss company’s drug infringes Amgen patents.
Read MoreAtheroGenics goes bankrupt
US-based biopharmaceutical company AtheroGenics has filed for Chapter 11 bankruptcy citing a “substantial debt burden”.
Read MoreEli Lilly acquires ImClone for $6.5 billion
Eli Lilly is to take over ImClone Systems after the companies ended speculation and agreed a definitive merger deal where drug giant Lilly will pay out $6.5 billion for the biopharmaceutical company – some $70 per share.
Read More- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
